NCT06536088

Brief Summary

In this study, the spatiotemporal gait parameters of symptomatic femoroacetabular impingement (FAI) patients scheduled for hip arthroscopy are evaluated. Radiological measurements, including the Alpha angle (AA), Lateral Center-Edge Angle (LCEA), and Kellgren-Lawrence (KL) osteoarthritis classification, are recorded from patient files. The relationship between these radiological measurements and walking parameters is assessed. Additionally, the spatiotemporal gait parameters of FAI patients are compared with those of a healthy control group. Walking assessments provide valuable insights into how Femoroacetabular Impingement (FAI) affects movement and aid in evaluating treatment outcomes. Research indicates that individuals with FAI experience reduced hip motion and slower walking speeds. By analyzing spatiotemporal gait parameters-such as gait velocity, cadence, step length, and vertical center of mass-the impact of FAI on walking can be better understood, leading to the development of targeted treatment strategies. The goal is to explore the correlation between these gait parameters and imaging-based FAI characteristics in affected individuals.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

July 29, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 2, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

August 2, 2024

Status Verified

July 1, 2024

Enrollment Period

2.7 years

First QC Date

July 29, 2024

Last Update Submit

July 31, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Gait velocity

    Gait velocity, also known as walking speed, is a crucial parameter in spatiotemporal gait analysis. It refers to the rate at which an individual walks over a given distance and is typically measured in meters per second (m/s).

    Baseline

  • Cadence

    Cadence refers to the number of steps a person takes per minute while walking.

    Baseline

  • Step length

    Step length refers to the distance covered between two consecutive footfalls of opposite feet.

    Baseline

  • Vertical center of mass

    The vertical center of mass refers to the vertical position of the body's center of mass during walking. It is the point where the body's mass is considered to be concentrated and it fluctuates as the person moves.

    Baseline

Study Arms (2)

Patient with Femoroacetabular Impingement

Symptomatic femoroacetabular impingement patients scheduled for hip arthroscopy

Other: Walking assesment

Control group

Healthy indivicuals without Femoroacetabular Impingement

Other: Walking assesment

Interventions

Spatiotemporal walking assessments are performed using the Gait Analyzer app (version 0.9.95.0) on a smartphone. Participants who can walk independently without assistance walk a 25-meter path at their normal speed, with the smartphone securely attached to their body above the third lumbar vertebra using a belt. The app records gait velocity, cadence, step time, step length, and vertical center of mass for all participants.

Control groupPatient with Femoroacetabular Impingement

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for hip arthroscopy due to Femoroacetabular impingement syndrome at the Department of Orthopedics and Traumatology, Gazi University Faculty of Medicine, along with a healthy control group matched for age and gender, will be included in the study.

You may qualify if:

  • Patients with femoroacetabular impingement scheduled for hip arthroscopy

You may not qualify if:

  • Severe hip osteoarthritis
  • Hip dysplasia
  • Previous ipsilateral and/or contralateral hip surgery,
  • Any orthopedic or neurologic pathology that may affect gait patterns

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Hospital

Ankara, 06500, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Femoracetabular Impingement

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ulunay Kanatlı, Professor

    Gazi University

    STUDY DIRECTOR

Central Study Contacts

İnci H Ayas, Msc

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 29, 2024

First Posted

August 2, 2024

Study Start

January 1, 2022

Primary Completion

September 30, 2024

Study Completion

December 30, 2024

Last Updated

August 2, 2024

Record last verified: 2024-07

Locations